CuraGen Presents Update on Clinical Development Program for,Belinostat ( 706-758-4315 (internationa...)

CuraGen Presents Update on Clinical Development Program for,Belinostat

706-758-4315 (international) Passcode: 2474675 Webcast: Access to the live webcast and presentation are available at http://www.curagen.com

A replay of the conference call will be available starting at 11:30 a.m. Eastern time on Tuesday, June 12, 2007 through Sunday, August 12, 2007 by dialing 800-642-1687 (domestic) or 706-645-9291 (international). The passcode for the replay is 2474675. An archive of the webcast will also be accessible at http://www.curagen.com.

Reprints of the poster presentations are available on CuraGen's website at www.curagen.com , or by emailing . info@curagen.com

About Belinostat

Belinostat is a promising small molecule HDAC inhibitor being investigated for its role in the treatment of a wide range of solid and hematologic malignancies either as a single-agent, or in combination with other active anti-cancer agents, including 5-FU, carboplatin, paclitaxel, cis-retinoic acid, azacitidine, doxorubicin and Velcade(R) (bortezomib) for Injection. HDAC inhibitors represent a new mechanistic class of anti-cancer therapeutics that target HDAC enzymes and have been shown to: arrest growth of cancer cells (including drug resistant subtypes); induce apoptosis, or programmed cell death; promote differentiation; inhibit angiogenesis; and sensitize cancer cells to overcome drug resistance when used in combination with other anti- cancer agents.

Intravenous belinostat is currently being evaluated in multiple clinical trials as a potential treatment for multiple myeloma, T- and B-cell lymphomas, AML, mesothelioma, liver, soft tissue sarcoma, colorectal, ovarian cancers, either alone or in combination with anti-cancer therapies. An oral formulation of beli
'"/>

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
2. CuraGen Announces New Preclinical Results with Belinostat and Velafermin to be Presented at AACR Annual Meeting
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting

Post Your Comments:

(Date:11/20/2009)...Nov. 20 Reportlinker.com announces... its catalogue. ,, Global Self Monitoring Bloo...ive Growth ,, http://www.reportlinker.com/p0...-(SMBG )-Increasing-Adoption-to-Drive-Growth.html#...mpaign=prnewswire ,, Description ,, Globa...

(Date:11/20/2009)...Nov. 20 Reportlinker.com announces... its catalogue. ,, Global Markets for Assisted...ortlinker.com/p0164742/Global-Markets-for-Assisted...ire&utm_medium=pr&utm_campaign=prnewswire ...overs the U.S., 15 Countries in Europe and Japan. ...

(Date:11/20/2009).... 20 Cyberonics, Inc. (N...sident and Chief Executive Officer, and Greg Brown...st Annual Piper Jaffray Health Care Conference in ...M EST. The conference session and webcast will be.... Piper Jaffray will host a webcast of the presen...

Breaking Medicine Technology:Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 2 Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 3 Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 4 Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 5 Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 6 Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 7 Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth 8 Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2 Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2 WAND Point of Sale Solutions Integrate U are U 28R 29 Fingerprint Biometrics From DigitalPersona for Quick Service Restaurants 10425 1 WAND Point of Sale Solutions Integrate U are U 28R 29 Fingerprint Biometrics From DigitalPersona for Quick Service Restaurants 10425 2 WAND Point of Sale Solutions Integrate U are U 28R 29 Fingerprint Biometrics From DigitalPersona for Quick Service Restaurants 10425 3 Leg Clots May Not Travel to Lungs 59796 1 Leg Clots May Not Travel to Lungs 59796 2 Leg Clots May Not Travel to Lungs 59796 3 Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 1 Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 2 Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 3 Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 4 Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 5 Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 6

[0] Reportlinker Adds Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth [0] Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 [0] Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference

...-May 14, 2007 - Oculus Innovative,Sciences, Inc. (...nology was the subject of a poster presentation at...conference that was held in,Glasgow, Scotland this... About an Antimicrobial,Solution in the Treatment ... Harding infection criteria to evaluate the,perfor...

...ion and Symptom Severity; New,Resources for Patien...USNewswire/ -- A new survey,released today by the ...ma sufferers are not exactly breathing easy these ...ma medication categories,somewhat or not at all, a...geable adult patients tend to be about asthma. In ...

Other Medicine Technology:Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 2 Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 3 New Survey Finds Troubling Data on American Asthma Sufferers 2 New Survey Finds Troubling Data on American Asthma Sufferers 3 New Survey Finds Troubling Data on American Asthma Sufferers 4 New Survey Finds Troubling Data on American Asthma Sufferers 5 New Survey Finds Troubling Data on American Asthma Sufferers 6

Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference New Survey Finds Troubling Data on American Asthma Sufferers

(Date:11/21/2009)..., WASHINGTON, Nov. 21 /PRNewswire-USNewswire/ -...liminate onchocerciasis (river blindness) in the A...f the disease in recent years, as evidenced by a 3... mass drug administration in six endemic countries...meeting of the American Society of Tropical Medici...

(Date:11/21/2009)... NH based medical credentialing s...its industry to form a partnerhsip with Amerinet, ...his partnership will help to transform quality car... (Vocus) November 21, 2009 -- ISG Group, L...nced a new agreement with Amerinet Inc., a leading...

(Date:11/21/2009)... Eric J. Hall, president and chie...of America (AFA) issued the following statement re...ction as part of the new annual wellness for Medic...and Affordable Care Act" that was introduced ...Y (PRWEB) November 21, 2009 -- Eric J. Hall, presi...

(Date:11/20/2009)..., Pioneering Neurologist Closer to Understanding ...0 Dr. Jeremy Schmahmann... and neurologist at the Massachusetts General Hosp...d his laboratory,s research on the new field of st...Dlink Foundation. ,, Dr. Schmahmann is an award...

(Date:11/20/2009)... , WASHINGTON, Nov. 20 /PRNewswire-USNewswire...ops urged the Senate to make essential changes its...ral law on abortion funding and conscience protect... immigrants and include strong provisions for adeq...enate health care bill an "enormous disappointment...

Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2 Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3 Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4 Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2 Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2 Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3 Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2 Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2

[0] River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries [0] IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care [0] Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform [0] MINDlink Foundation Launches to Connect the Cerebellum to Cures [0] U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability

...Patient Volumes Seen in Houston Physician-Owned Ho...rs-InterStudy , , NASHVILLE, Tenn., March 23 Hea...ed care market intelligence, reports that while Te... actually yield increasing challenges for this sec...

...ne, Ph.D. Honored for Distinguished Service in the... 23 NovaBay Pharmaceuticals, Inc. (NYSE Alternext...st M. Frederick Hawthorne, Ph.D., a member of the ...). Dr. Hawthorne, who is co-director of the Inter...

...n is One of Three FDA Approvals Spanning Lilly Neu...U.S. Food and Drug Administration (FDA) has approv... fluoxetine HCl capsules), Eli Lilly and Company (... "Living with major depressive disorder is difficu...

... March 23 According to the National Bureau of Eco...ce December 2007 and nearly half of U.S. residents... Winfrey replaced her annual ,Favorite Things, hol...cted to grow into a trillion dollar trade by 2010....

...e "2008 European Tissue Sealants & Topical Hem...s conferred on Nycomed in recognition of its revol...al patch, TachoSil is poised to be the future of t...d, with TachoSil, is the sole company in the marke...

... Gilbert joins The Association after serving a... for the American Red Cross in Washington, D.C. In...bert was responsible for eight service areas and 7...ore than $30 million in chapter grants. , ...

In Texas, Favorable Regulations for Physicians May Backfire in Light of Market Downturn NovaBay Pharmaceuticals' Scientific Advisor Receives American Chemical Society's Highest Award FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression Consumers Redefine Value in the Recession: Sauna Sales Prove Preventive Health Is an Essential Investment Frost & Sullivan Commends Nycomed for Excellence in Product Differentiation Innovation Jane H. Gilbert Appointed President and Chief Executive Officer of The ALS Association

...t Manager (IM) is an instrument and LIS independen...bles laboratories to work more efficiently than ev...hat stands between instrument or medical devices a... gaps in functionality between the two, as a conne...

L'Anthony 40

... detecting and grading acquired color deficiency. ...ion of saturation thresholds for bluish pigment co...nces between normal and acquired vision defects. C... discriminates between congenital and acquired dys...

... a rapid field or laboratory test for the differen...mple, two-step test provides results in 10 minutes...ient outcomes. , ,Intended use: The NOW® H...ostic test for the detection of Hepatitis B surfac...

Medicine Products:

Instrument Manager™L'Anthony 40 Sahlgrens NOW® Hepatitis B Test

( 706-758-4315 (internationa...)CuraGen Presents Update on Clinical Development Program for,Belinostat,Health